Immunoassay Market Share, Size by Product (Reagents & Kits), by Technology (Radioimmunoassay (RIA)), by Application, by End use, Region (Asia Pacific, Europe, North America, Middle East, and Africa, Latin America), and forecast period-2022 – 2030 (Updated Version Available)

Report ID - MRC_750 | Pages - 185 | Category - Healthcare and Pharma

Immunoassay Market Insights :

Immunoassay Market is projected to be worth USD 48.26 Billion by 2030, registering a CAGR of 5.7% CAGR during the forecast period (2022-2030), the market was valued at USD 29.30 Billion in 2021. In 2021, the market was dominated by the infectious disease testing sector, which had a revenue share of over 30.0%. Hospitals led the immunoassay market in 2021, accounting for a revenue share of approximately 31.2%. In 2021, North America had the greatest revenue share 39.4%, and is expected to continue to lead the market for the duration of the research.

Immunoassay Market Dynamics:

Immunoassay is a process for identifying or quantifying particular proteins or other compounds using their abilities to act as antigens or antibodies. In the drug development and pharmaceutical sectors, immunoassays have been extensively used in many crucial areas of pharmaceutical analysis, including therapeutic medication monitoring, disease diagnostics, and clinical pharmacokinetic and bioequivalence investigations.

How much is the Immunoassay Market worth ?

img

Get Free Sample PDF

Driver:

The primary diagnosis for several infections and pathophysiological disorders is now immunoassays. Another significant driver propelling the market’s expansion is the rising demand for items used in the early-stage diagnosis of medical conditions. Immunodiagnostic assays are now being utilized for prevention and management due to a load of chronic diseases, the high prevalence of infection, and the COVID-19 pandemic. Immunoassay tests, which provide accurate and affordable detection of infections or target molecules, are regarded as a crucial diagnostic tool. These tests are used to diagnose both very prevalent and chronic disorders.

Restraint:

Nucleic acid probes and molecular diagnostics are based on a particular genetic makeup. Therefore, it is anticipated that more molecular diagnostic tests would be used throughout the projection period, which could limit the immunoassay market growth.

COVID-19 Analysis of Immunoassay Market:

The Immunoassay market has been severely impacted since the COVID-19 epidemic in many different parts of the world. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects on China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the Immunoassay market is moderate.

Immunoassay Market Report Coverage:

Report Attributes Report Details
Study Timeline 2016-2030
Market Size in 2030 (USD Billion) 48.26 Billion
CAGR (2022-2030) 5.7%
By Product Reagents & Kits – ELISA Reagents & Kits, Rapid Test Reagents & Kits, ELISPOT Reagents & Kits, Western Blot Reagents & Kits, Other Reagents & Kits, Analyzers/Instruments, Open Ended Systems, Closed Ended Systems

Software & Services

By Technology Radioimmunoassay (RIA), Enzyme Immunoassays (EIA)Rapid Test – Chemiluminescence Immunoassays (CLIA), Fluorescence Immunoassays (FIA), Others
By Application Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Others
By End Use Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, Others
By geography North America– (U.S., Canada, Mexico)

Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)

Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)

Latin America- (Brazil, Argentina, Chile, Rest of Latin America)

The Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)

Key Players Siemens Healthineers, bioMérieux SA, Abbott Laboratories, Danaher Corporation (Beckman Coulter), Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc.

Immunoassay Market Segment Analysis:

By Product

With a revenue share of more than 60.7% in the immunoassay market in 2021, the reagents and kits segment had a leading position. The section is expected to maintain its lead over the projection period. The demand for immunoassay reagents and kits for diagnostic purposes is high due to the increase in viral and autoimmune illnesses. In addition, it is projected that the acceptance and release of novel immunoassay kits will support the segment’s growth.

Immunoassay Market Size

By Technology

The EIA/ELISA segment led the immunoassay market with a revenue share of more than 60.0% in 2021. This method has several significant advantages over immunoelectrophoresis and immunodiffusion, including faster assays, more precise results, and a need for fewer antisera for analysis.

The target analyte can be found using a quick test, also known as a lateral flow immunoassay, which does not require specific equipment. The fast test technique is useful for a variety of diseases, including those brought on by Campylobacter, Legionella, Listeria, Salmonella, and Zika. Additionally, monoclonal antibodies are utilized to precisely identify the target analyte for immunoglobulin M (IgM), immunoglobulin A (IgA), immunoglobulin G (IgG), and immunoglobulin D (IgD).

immunoassay market by technology

By Application

In 2021, the market was dominated by the infectious disease testing sector, which had a revenue share of over 30.0%. Over the forecast period, the segment is expected to keep up its lead. The surge in the prevalence of infectious diseases like HIV, malaria, influenza, and the new COVID-19 is to blame for this high share. The market is also being driven by the introduction of new products in the field of infectious disease diagnostics.

One of the main drivers of the market for immunoassays during the forecast period is the rising incidence of cancer cases worldwide. The International Agency for Research on Cancer said that while there were around 9.6 million cancer-related deaths in 2018, the incidence of the disease was predicted to be 18.1 million new cases. Therefore, it is projected that an increase in cancer incidence will accelerate the adoption of immunoassays.

By End Use

Hospitals led the immunoassay market in 2021, accounting for a revenue share of approximately 31.2%. The strong growth of this market segment is a result of the increase in hospitals. The need for hospitals with cutting-edge amenities has surged as a result of the continuous developments in the healthcare sector. Further, other segments such as blood banks, clinical laboratories, pharmaceutical, and biotech companies, academic research centers, and others are expected to supplement the growth of the market.

By Region

The regional segment includes regions such as Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. In 2021, North America had the greatest revenue share 39.4%, and is expected to continue to lead the market for the duration of the research. This can be attributable to two factors such as the simple accessibility of technologically enhanced diagnostic tools, as well as the increased demand for diagnostics brought on by the rise in cancer incidence. The high prevalence of infectious diseases including HIV, TB, and influenza in the area is also driving up the demand for diagnosis and treatment.

Immunoassay Market Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Product launches have accelerated the growth of the Immunoassay market. Key players in the market include-

  • Siemens Healthineers
  • bioMérieux SA
  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • Quidel Corporation
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson, and Company
  • Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.

Table of Content

  1. Introduction
    • Market Introduction
    • Market Research Methodology
      • Research Process
      • Primary Research
      • Secondary Research
      • Data Collection Technique
      • Data Sources
    • Market Estimation Methodology
      • Limitations of the Study
    • Product Picture of Immunoassay
    • Global Immunoassay Market: Classification
    • Geographic Scope
    • Years Considered for the Study
    • Research Methodology in brief
    • Parent Market Overview
    • Overall Immunoassay Market Regional Demand
    • Research Programs/Design
    • Market Breakdown and Data Triangulation Approach
    • Data Source
    • Secondary Sources
    • Primary Sources
    • Primary Interviews
    • Average primary breakdown ratio
  2. Market Dynamics
    • Drivers
      • Drivers
    • Restraints
      • Restraints
    • Opportunity
      • Impact forces on market dynamics
      • Impact forces during the forecast years
    • Industry Value Chain
      • Upstream analysis
      • Downstream analysis
      • Therapeutic
      • Direct Channel
      • Indirect Channel
    • Potential Customers
    • Manufacturing/Operational Cost Analysis
    • Pricing Analysis by Region
    • Key Product Landscape
    • Regulatory Analysis
    • Porter’s Analysis
      • Supplier Power
      • Buyer Power
      • Substitution Threat
      • Threat from New Entry
      • Competitive Rivalry
    • PESTEL Analysis
    • Political Factors
    • Economic Factor
    • Social Factors
    • Technological Factor
    • Environmental Factors
    • Legal Factor
    • Covid-19 impact on Global Economy
    • Covid-19 impact on Immunoassay Market demand 
    • Post-Covid Impact on Immunoassay Market Demand
    • Impact Analysis of Russia-Ukraine Conflict
  3. Global Immunoassay Market Segmentation, Revenue (USD Billion), (2022-2030)
    • By Product
      • Reagents & Kits
        • ELISA Reagents & Kits
        • Rapid Test Reagents & Kits
        • ELISPOT Reagents & Kits
        • Western Blot Reagents & Kits
        • Other Reagents & Kits
      • Analyzers/Instruments
        • Open Ended Systems
        • Closed Ended Systems
      • Software & Services
    • By Technology
      • Radioimmunoassay (RIA)
      • Enzyme Immunoassays (EIA)Rapid Test
        • Chemiluminescence Immunoassays (CLIA)
        • Fluorescence Immunoassays (FIA)
      • Others
    • By Application
      • Therapeutic Drug Monitoring
      • Oncology
      • Cardiology
      • Endocrinology
      • Infectious Disease Testing
      • Autoimmune Diseases
      • Others
    • By End Use
      • Hospitals
      • Blood Banks
      • Clinical Laboratories
      • Pharmaceutical and Biotech Companies
      • Academic Research Centers
      • Others
  1. Global Immunoassay Market Overview, By Region
    • North America Immunoassay Market Revenue (USD Billion), by Countries, (2022-2030)
      • US
        • By Product
        • By Technology
        • By Application
        • By End Use
      • Canada
      • Mexico
    • Europe Immunoassay Market Revenue (USD Billion), by Countries, (2022-2030)
      • France
      • UK
      • Spain
      • Russia
      • Italy
      • BENELUX
    • Asia Pacific Immunoassay Market Revenue (USD Billion), by Countries, (2022-2030)
      • China
      • Japan
      • Australia
      • South Korea
      • India
      • ASEAN
  1. Latin America Immunoassay Market Revenue (USD Billion), by Countries, (2022-2030)
    • Brazil
    • Argentina
    • Chile
  2. Middle East and Africa Immunoassay Market Revenue (USD Billion), by Countries, (2022-2030)
    • GCC
    • Turkey
    • South Africa
  3. Global Immunoassay Market Revenue: Competitive Analysis, 2021
    • Key strategies by players
    • Revenue (USD Billion and %), By manufacturers, 2021
    • Player Positioning by Market Players, 2021
  4. Competitive Analysis
    • Siemens Healthineers
      • Business Overview
      • Business Financials (USD Billion)
      • Product Category, Source, and Specification
      • Main Business/Business Overview
      • Geographical Analysis
      • Recent Development
      • Swot Analysis
    • Siemens Healthineers
    • bioMérieux SA
    • Abbott Laboratories
    • Danaher Corporation (Beckman Coulter)
    • Quidel Corporation
    • Ortho Clinical Diagnostics
    • Sysmex Corporation
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson, and Company
    • Hoffmann-La Roche AG
    • Thermo Fisher Scientific, Inc.
  5. Market Research Findings & Conclusion

Disclaimer 

Research Methodology

The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.

Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.

Immunoassay Market Share, Size by Product (Reagents & Kits), by Technology (Radioimmunoassay (RIA)), by Application, by End use, Region (Asia Pacific, Europe, North America, Middle East, and Africa, Latin America), and forecast period-2022 – 2030 (Updated Version Available)
Back to top button